J. Bertrams

3.4k total citations
88 papers, 2.2k citations indexed

About

J. Bertrams is a scholar working on Immunology, Genetics and Surgery. According to data from OpenAlex, J. Bertrams has authored 88 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 31 papers in Genetics and 20 papers in Surgery. Recurrent topics in J. Bertrams's work include Diabetes and associated disorders (26 papers), Pancreatic function and diabetes (14 papers) and Diabetes Management and Research (12 papers). J. Bertrams is often cited by papers focused on Diabetes and associated disorders (26 papers), Pancreatic function and diabetes (14 papers) and Diabetes Management and Research (12 papers). J. Bertrams collaborates with scholars based in Germany, United States and Netherlands. J. Bertrams's co-authors include E. Kuwert, Max P. Baur, F. A. Gries, H. Grosse‐Wilde, Hubert Kolb, Christian Rittner, S Scholz, Sung-Hong Joe, JL Gottschall and Michael J. MacDonald and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

J. Bertrams

84 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Bertrams Germany	24	948	943	750	456	273	88	2.2k
G. F. Bottazzo United Kingdom	30	986 1.0×	1.1k 1.2×	596 0.8×	1.2k 2.7×	298 1.1×	65	3.2k
Mauro Congia Italy	25	1.0k 1.1×	1.1k 1.1×	653 0.9×	412 0.9×	253 0.9×	50	2.7k
GianFranco Bottazzo United Kingdom	12	829 0.9×	1.6k 1.7×	1.3k 1.7×	1.3k 2.9×	184 0.7×	16	3.1k
M. A. Farquharson United Kingdom	21	579 0.6×	1.2k 1.3×	993 1.3×	774 1.7×	84 0.3×	37	2.2k
Arno R. van der Slik Netherlands	26	1.3k 1.3×	547 0.6×	412 0.5×	270 0.6×	117 0.4×	47	2.0k
B. R. Hawkins Hong Kong	26	598 0.6×	409 0.4×	223 0.3×	249 0.5×	268 1.0×	73	1.7k
Helena Reijonen Finland	36	1.4k 1.4×	2.5k 2.6×	1.6k 2.2×	1.4k 3.1×	124 0.5×	97	3.6k
Anjli Kukreja United States	17	1.8k 1.9×	701 0.7×	281 0.4×	249 0.5×	93 0.3×	25	2.5k
John Prehn United States	23	1.6k 1.7×	642 0.7×	339 0.5×	39 0.1×	453 1.7×	41	2.6k
Zdenka Fronek United States	10	912 1.0×	387 0.4×	131 0.2×	94 0.2×	454 1.7×	13	1.4k

Countries citing papers authored by J. Bertrams

Since Specialization

Citations

This map shows the geographic impact of J. Bertrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bertrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bertrams more than expected).

Fields of papers citing papers by J. Bertrams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bertrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bertrams. The network helps show where J. Bertrams may publish in the future.

Co-authorship network of co-authors of J. Bertrams

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bertrams. A scholar is included among the top collaborators of J. Bertrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bertrams. J. Bertrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuglin, B., J. Bertrams, H Kolb, & F. A. Gries. (2008). Früherkennung des Typ-I-Diabetes: Grenzen, Möglichkeiten und Perspektiven. DMW - Deutsche Medizinische Wochenschrift. 114(19). 762–767.

Labenz, Joachim, M. Stolte, A.L. Blum, et al.. (1995). Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.. Gut. 37(1). 39–43. 99 indexed citations

Martin, Stéphan, E. F. Lampeter, F. A. Gries, et al.. (1995). Autoantibodies to the islet antigen ICA 69 occur in IDDM and in rheumatoid arthritis. Diabetologia. 38(3). 351–355. 41 indexed citations

Labenz, Joachim, G. H. Rühl, J. Bertrams, & G Börsch. (1994). Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.. PubMed. 89(5). 726–30. 35 indexed citations

Lampeter, E. F., Hubert Kolb, Dieter Lohmann, et al.. (1994). Inflammatory islet damage in patients bearing HLA-DR 3 and/or DR 4 haplotypes does not lead to islet autoimmunity. Diabetologia. 37(5). 471–475. 7 indexed citations

Labenz, Joachim, G. H. Rühl, J. Bertrams, & G Börsch. (1994). Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease. Alimentary Pharmacology & Therapeutics. 8(3). 323–327. 18 indexed citations

Lampeter, E. F., F. A. Gries, Hubert Kolb, et al.. (1993). Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. The Lancet. 341(8855). 1243–1244. 160 indexed citations

Purrmann, J, Gabriele Arendt, S. Cleveland, et al.. (1992). Association of Crohnʼs Disease and Multiple Sclerosis. Is There a Common Background?. Journal of Clinical Gastroenterology. 14(1). 43–46. 36 indexed citations

Purrmann, J, J. Bertrams, Michael Knapp, et al.. (1990). Gene and Haplotype Frequencies of HLA Antigens in 269 Patients with Crohn's Disease. Scandinavian Journal of Gastroenterology. 25(10). 981–985. 15 indexed citations

10.

Kuglin, B., et al.. (1990). Antibodies to Proinsulin and Insulin as Predictive Markers of Type 1 Diabetes. Diabetic Medicine. 7(4). 310–314. 12 indexed citations

11.

Schneider, Peter M., et al.. (1990). Null alleles of human complement C4. Evidence for pseudogenes at the C4A locus and for gene conversion at the C4B locus.. The Journal of Experimental Medicine. 171(1). 129–140. 65 indexed citations

12.

Kolb, Hubert, et al.. (1988). Prospective analysis of islet cell antibodies in children with Type 1 (insulin-dependent) diabetes. Diabetologia. 31(4). 189–194. 37 indexed citations

13.

Bertrams, J., Dale D. Dykes, Hans Eiberg, et al.. (1986). Proposal for the Nomenclature of Human Plasminogen (PLG) Polymorphism. Vox Sanguinis. 51(3). 244–248. 20 indexed citations

14.

Bertrams, J.. (1978). Immunogenetical aspects of multiple sclerosis with special regard to the HLA-histocompatibility system.. PubMed. 56(6). 506–15. 1 indexed citations

15.

Bertrams, J., et al.. (1974). [Histocompatibility (HL-A-)antigens of 1000 blood donors: a contribution to setting-up a platelet-, leukocyte- and bone-marrow-donor bank (author's transl)].. PubMed. 148(1). 73–91. 3 indexed citations

16.

Bertrams, J., et al.. (1974). HL-A ANTIGENS IN MULTIPLE SCLEROSIS. The Lancet. 303(7869). 1287–1287. 15 indexed citations

17.

Bertrams, J., et al.. (1974). [Genetic factors in psoriasis vulgaris: histocompatibility (HL-A)-ANTIGENS].. PubMed. 25(1). 39–39. 5 indexed citations

18.

Bertrams, J., et al.. (1974). [Presence of Australia antigen, histocompatibility (HL-A) antigens, and autolymphocytotoxins (CoCoCy) during different forms of hepatitis and cirrhosis].. PubMed. 227(1-4). 372–7. 1 indexed citations

19.

Bertrams, J., et al.. (1973). [Australia antigen, HL-A antigens and lymphocyte autoantibodies in chronic aggressive and chronic persisting hepatitis].. PubMed. 79. 642–4.

20.

Bertrams, J., et al.. (1971). HL‐A phenotype and gene frequencies in the German Ruhr area population. European Journal of Immunology. 1(4). 306–309. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact